Rephonic
Artwork for Biotech 2050 Podcast

Biotech 2050 Podcast

Biotech 2050
Biotechnology
Oncology
Cell Therapy
Ophthalmology
Gene Therapy
Aging Biology
Biotech
KRAS G12V
Venture Capital
Precision Medicine
Microglia
Cancer Metastasis
AI In Drug Development
Gene Editing
Cystic Fibrosis
Drug Discovery
Clinical Trials
Precision Oncology
Breast Cancer
Sloan Kettering

Biotech2050 Podcast is a think tank chronicling the disruptions changing the biotech industry over the next 50 years.

PublishesWeeklyEpisodes256Founded6 years ago
Number of ListenersCategory
Science

Listen to this Podcast

Artwork for Biotech 2050 Podcast

Latest Episodes

Synopsis: At the heart of JPM 2026’s biotech buzz, Alok Tayi sits down with Fred Aslan, CEO of Artiva, to explore how bold platform bets, scalable cell therapies, and autoimmune breakthroughs could reshape medicine. Fred traces his journey from medic... more

Synopsis: At JPM 2026 in San Francisco, Alok Tayi welcomes Michelle Werner, CEO of Alltrna, to Biotech 2050 for a powerful conversation at the intersection of personal mission, platform biology, and rare-disease drug development. Michelle traces her ... more

Synopsis: From managing a theme park in Canada to leading the U.S. business of one of the world’s largest privately held pharma companies, Brian Hilberdink’s journey is anything but conventional. Live from JPM 2026 in San Francisco, Biotech 2050 host... more

Synopsis: Fresh from the JPM 2026 in San Francisco, Alok Tayi welcomes Johan Luthman, Executive Vice President of R&D at Lundbeck, for a sweeping, deeply personal conversation on the future of neuroscience drug development. From his early days as a S... more

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Recent Guests

Fred Aslan
CEO of Artiva
Artiva
Episode: Fred Aslan, Artiva CEO, on Cell Therapy’s Next Wave, RA Trials & Scalable NK Platforms
Michelle Werner
CEO of Alltrna with over 20 years of experience in pharmaceutical drug development
Alltrna
Episode: Michelle Werner, CEO of Alltrna, on tRNA Platforms, Rare Disease & Drug Innovation
Johan Luthman
EVP of R&D at Lundbeck
Lundbeck
Episode: Johan Luthman, Lundbeck EVP R&D, on Rebuilding Neuroscience Pipelines & Drug Discovery
Christophe Bourdon
CEO of LEO Pharma
LEO Pharma
Episode: Christophe Bourdon, LEO Pharma CEO, on Dermatology Innovation, Rare Disease & Scalable Growth
Matt Gline
CEO of Roivant Sciences
Roivant Sciences
Episode: Matt Gline, Roivant Sciences CEO, on Clinical Breakthroughs, Capital Discipline & Building Biotech
Jay Hartenbach
President and COO of Diakonos Oncology
Diakonos Oncology
Episode: Jay Hartenbach, President & COO, Diakonos Oncology on Reprogramming Cancer Immunity Breakthrough
John Lepore
CEO of ProFound Therapeutics and CEO Partner at Flagship Pioneering
ProFound Therapeutics
Episode: John Lepore, CEO & President - ProFound Therapeutics, on Proteome, AI, & Bold First-in-Class Drugs
Jason Kelly
CEO and co-founder of Ginkgo Bioworks
Ginkgo Bioworks
Episode: Jason Kelly - Ginkgo Bioworks CEO and Co-Founder on Automation, AI Data & Biotech’s Reset
Arun Swaminathan
CEO of Coya Therapeutics
Coya Therapeutics
Episode: Arun Swaminathan: Coya CEO on Neuroinflammation, BD Strategy & Patient-Driven Biotech

Hosts

Rahul Chaturvedi
Co-founder of the podcast and today's host
Alok Tayi
CEO and co-founder of VibeBio

Reviews

4.8 out of 5 stars from 177 ratings
  • Wonderful Diversity of Leadership

    Bravo! From patient focus, to capital formation, to commercial expertise… these conversations are engaging and meaningful to the bio ecosystem.

    Apple Podcasts
    5
    Sae36
    United States2 years ago
  • Sounds like a sales pitch

    I was hoping to hear about some interesting technology, but the first 20 minutes sounded like a sales pitch and slagging competitors. I ran out of patience so couldn’t finish it.

    Apple Podcasts
    1
    John-Hernry2
    Australia5 years ago
  • Intense knowledge to absorb

    Very well done podcast with tons of information that sounds like a freaking french to me but, after while you listening the podcast, you'll realize that you are smarter than before... damn... keep up the good work...

    Apple Podcasts
    5
    bimmerx
    Canada5 years ago
  • Finally!

    Love where this is going, been looking for a podcast to keep me up on the latest and greatest happenings in biotech.

    Apple Podcasts
    5
    TR-iumph
    United States6 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Listeners appreciate the engaging and meaningful conversations that touch upon diverse topics within the biotechnology ecosystem.
Overall, many find the content to be informative and enlightening, often gaining valuable insights into the biotech sector.
Some listeners have expressed frustration with episodes that come across as overly promotional or sales-focused rather than informative.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#51
Russia/Science
Apple Podcasts
#169
South Korea/Science
Apple Podcasts
#176
Switzerland/Science
Apple Podcasts
#208
Israel/Science
Apple Podcasts
#226
Belgium/Science
Apple Podcasts
#238
Singapore/Science

Talking Points

Recent interactions between the hosts and their guests.

Fred Aslan, Artiva CEO, on Cell Therapy’s Next Wave, RA Trials & Scalable NK Platforms
Q: If you were to give advice to others who have an interesting platform or technology and are trying to figure out what indications to pursue, any particular piece of advice you'd offer?
Focus on areas that can have a transformational impact and be aware of the competitive landscape to find unique opportunities.
Fred Aslan, Artiva CEO, on Cell Therapy’s Next Wave, RA Trials & Scalable NK Platforms
Q: Any chance you could just give us a quick synopsis of the cell therapy space at writ large, as well as some of the key bottlenecks or challenges that you think are holding the field back at present?
Cell therapy has seen significant advancements, particularly with Auto CAR T, which has transformed cancer treatments. However, challenges include personalized manufacturing processes that are costly and time-consuming, as well as the need for scalable technologies.
Michelle Werner, CEO of Alltrna, on tRNA Platforms, Rare Disease & Drug Innovation
Q: How do you think about clinical trial design, given that you're not using the same nomenclature or the same labels that people often align to?
We plan to couple familiar nomenclature with our 'stop codon disease' definition as a way to characterize a large patient population.
Michelle Werner, CEO of Alltrna, on tRNA Platforms, Rare Disease & Drug Innovation
Q: As a pioneer in this novel modality and mechanism, any advice you have for the next wave of founders and CEOs trying to develop completely new modalities?
Learn from lessons from before and focus on the unique aspects of what is being pioneered.
Michelle Werner, CEO of Alltrna, on tRNA Platforms, Rare Disease & Drug Innovation
Q: What's one thing you think folks need to be thinking about in an early stage biotech that you learned while doing commercial work in a bigger pharma company?
It's important to understand the market and the business opportunity, which is not straightforward in rare diseases.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Biotech 2050 Podcast

What is Biotech 2050 Podcast about and what kind of topics does it cover?

Focused on the disruptions reshaping the biotechnology sector, discussions center around innovations, advancements, and the evolving landscape of drug development. Topics often include insights from industry leaders regarding AI's role in biotech, regulatory frameworks, and the importance of patient-centric approaches in therapeutic strategies. The podcast features extensive conversations with CEOs and thought leaders who share their experiences and visions for the future of biotechnology, allowing listeners to gain a deep understanding of current challenges and opportunities within the industry.

Where can I find podcast stats for Biotech 2050 Podcast?

Rephonic provides a wide range of podcast stats for Biotech 2050 Podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Biotech 2050 Podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Biotech 2050 Podcast get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Biotech 2050 Podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Biotech 2050 Podcast?

Rephonic provides comprehensive predictive audience data for Biotech 2050 Podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Biotech 2050 Podcast have?

To see how many followers or subscribers Biotech 2050 Podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Biotech 2050 Podcast?

These podcasts share a similar audience with Biotech 2050 Podcast:

1. The Readout Loud
2. Business Of Biotech
3. Biotech Hangout
4. BioCentury This Week
5. The Long Run with Luke Timmerman

How many episodes of Biotech 2050 Podcast are there?

Biotech 2050 Podcast launched 6 years ago and published 256 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Biotech 2050 Podcast?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Biotech 2050 Podcast?

Rephonic pulls ratings and reviews for Biotech 2050 Podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Biotech 2050 Podcast?

Rephonic provides full transcripts for episodes of Biotech 2050 Podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Biotech 2050 Podcast?

Recent guests on Biotech 2050 Podcast include:

1. Fred Aslan
2. Michelle Werner
3. Johan Luthman
4. Christophe Bourdon
5. Matt Gline
6. Jay Hartenbach
7. John Lepore
8. Jason Kelly

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days